Delivery Order SPE2DB20D3101-SPE2DB24FQWW0
Award Date 12/13/23
Potential Completion Date 12/14/23
Potential Value $1.3K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $5,369.63, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the supply of 4,568,174,760 units of the medication Clobazam 10 mg tablets. The contract is a firm fixed-price, non-set-aside award with a performance period extending through May 8, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,584.20 firm fixed-price delivery order is for the supply of 4,568,143,444 units of the prescription medication clobazam 10 mg tablets. The contract has an ultimate completion date of May 6, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,849.72 delivery order is for the supply of Clobazam 2.5 mg/ml suspension in 120 ml bottles. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC serves as the primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,860.31 firm-fixed-price delivery order is for the supply of 4,567,675,699 units of the pharmaceutical drug clobazam 10 mg tablets. The contract has an ultimate completion date of March 25, 2025 and is not designated under any set-aside program. AmerisourceBergen holds a significant $999,999,999 Indefinite...
- This is a $1,330.65 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 2.5 mg/ml clobazam suspension in a 120 ml bottle. The delivery order has an ultimate completion date of July 7, 2025. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global pharmaceutical...
- The U.S. Department of Defense, through the Defense Logistics Agency (DLA) Troop Support Medical, has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distributor. The contract, valued at $1,567.49, is for the provision of clobazam 10 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of clobazam 10 mg tablets. The $3,920.91 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a civilian agency providing medical supplies and equipment to the U.S. military. The contract has an ultimate completion date of October 23, 2024 and was not designated with a set-aside requirement, indicating open competition....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company owned by the parent company Cencora, Inc. The contract, valued at $14,334.29, is for the delivery of 4,562,953,178 units of the drug Clobazam 10 mg tablets. The contract has an ultimate completion date of December 1, 2023 and is structured as a Firm Fixed Price Delivery Order. No set-aside designation was used for this award. Amerisourcebergen holds a...
- This federal contract award, valued at $3,111.86, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,567,316,903 units of the prescription drug clobazam 10 mg tablet in 100-count bottles. The contract has a period of performance through February 20, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen...
- This federal contract award, valued at $1,209.71, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Clobazam 2.5 mg/ml suspension in 120 ml quantities. This is a Firm Fixed Price Delivery Order contract with a completion date of December 22, 2023. The contract was awarded on December 21, 2023 and was not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that...